Metraipolis › archive › dc_82070360375e

Toripalimab combined with FLOT chemotherapy as conversion therapy for gastric cancer with peritoneal metastasis: a single-arm, open-label, phase II trial — Europe PMC PMID:41206442

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41206442
DOI
10.1186/s12885-[numero omesso]-w
License (as archived)
solo-consultazione
Archived
2026-11-08T17:20:46.853Z
SHA-256 of the archived text
d48a707fba96331e32d57b1fa2d01c81008a8b2d8cf753d7891ff46e35682bba
Stable URL of this page
https://metraipolis.com/documento/dc_82070360375e

How to cite

Toripalimab combined with FLOT chemotherapy as conversion therapy for gastric cancer with peritoneal metastasis: a single-arm, open-label, phase II trial — Europe PMC PMID:41206442 — Europe PMC (en), https://europepmc.org/article/MED/41206442 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_82070360375e (Metraipolis archive dc_82070360375e, sha256 d48a707fba96331e32d57b1fa2d01c81008a8b2d8cf753d7891ff46e35682bba)
BibTeX
@misc{dc82070360375e,
  title = {Toripalimab combined with FLOT chemotherapy as conversion therapy for gastric cancer with peritoneal metastasis: a single-arm, open-label, phase II trial — Europe PMC PMID:41206442},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41206442},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_82070360375e; sha256 d48a707fba96331e32d57b1fa2d01c81008a8b2d8cf753d7891ff46e35682bba},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41206442. Agents can read the archived copy with the MCP tool read_document.